Patents by Inventor Burton Kendall

Burton Kendall has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4675803
    Abstract: A system is provided to receive and process information including a processor, an operator station and an interconnect processor. The interconnect processor is coupled to the processor by a first bus, and the interconnect processor is coupled to the operator station by a second bus.
    Type: Grant
    Filed: August 25, 1986
    Date of Patent: June 23, 1987
    Assignee: Measurex Corporation
    Inventors: Burton Kendall, Thomas King
  • Patent number: 4635189
    Abstract: A real-time distributed data-base system that stores in the local memory of each processor copies of only those variables necessary for execution of the programs in that processor. Performance is enhanced by using the absolute address of variables in each program reference, with automatic updating of all program references when the location of variables are changed. Flexibility in user application programming is enhanced by permitting combination and conditional updates of variables through the interaction of multiple processors.
    Type: Grant
    Filed: March 1, 1984
    Date of Patent: January 6, 1987
    Assignee: Measurex Corporation
    Inventor: Burton Kendall
  • Patent number: 4042586
    Abstract: 2-(3-Substituted amino-2-hydroxypropoxy)-3-substituted pyrazine compounds optionally having substituents in the 5 and/or 6 positions, possessing .beta.-adrenergic blocking properties are described. The products are prepared by reaction of a 2-chloro(or hydroxy)pyrazine with a 5-hydroxy-methyl(or sulfonyloxymethyl)oxazolidine followed by acid hydrolysis.
    Type: Grant
    Filed: June 6, 1975
    Date of Patent: August 16, 1977
    Assignee: Merck Sharp & Dohme (I.A.) Corporation
    Inventors: Burton Kendall Wasson, Leonard M. Weinstock
  • Patent number: 4011217
    Abstract: 4-[3-(Substituted amino)-2-acyloxypropoxy]-1,2,5-thiadiazole compounds, optionally substituted in the 3-position of the thiadiazole nucleus which exhibit .beta.-adrenergic blocking properties and thus are useful in the management of angina pectoris are described. The products are prepared by reaction of a 4-[3-(substituted amino)-2-hydroxypropoxy]-1,2,5-thiadiazole with the appropriate anhydride. The reaction is run under acidic conditions when the amino nitrogen is protonated.
    Type: Grant
    Filed: February 26, 1975
    Date of Patent: March 8, 1977
    Assignee: Merck Sharp & Dohme (I.A.) Corporation
    Inventor: Burton Kendall Wasson
  • Patent number: 3993656
    Abstract: There is described 1,8-naphthyridin-2(1H)-one compounds with bronchodilating and hypotensive properties prepared by reaction of 2,6-diaminopyridine with an appropriate .beta.-diketone providing a 2-aminonaphthyridine compound which upon treatment with nitrous acid is converted to the 2-oxo product. Alternatively, an appropriate .beta.-diketone can be reacted with an alkyl alkoxycarbonylacetimidate, the alkyl 2-aminonicotinate thus formed converted to the hydrazide, which upon treatment with a sulfonyl halide forms the N-sulfonyl hydrazide derivative. This intermediate is reacted with an alkali metal carbonate to provide the 2-aminonicotinaldehyde which upon reaction with an ester of a substituted aliphatic carboxylic acid provides the desired product. In some cases the aminonicotinaldehyde is generated in situ in the presence of the ester thereby giving the desired product in one step from the N-sulfonyl hydrazide derivative.
    Type: Grant
    Filed: February 20, 1975
    Date of Patent: November 23, 1976
    Assignee: Merck & Co., Inc.
    Inventors: Clarence Stanley Rooney, Haydn Windsor Richard Williams, Burton Kendall Wasson
  • Patent number: 3946009
    Abstract: 2-(3-Substituted amino-2-hydroxypropoxy)-3-substituted pyrazine compounds optionally having substituents in the 5 and/or 6 positions, possessing .beta.-adrenergic blocking properties are described. The products are prepared by reaction of a 2-chloro(or hydroxy)pyrazine with a 5-hydroxy-methyl(or sulfonyloxymethyl)oxazolidine followed by acid hydrolysis.
    Type: Grant
    Filed: October 19, 1973
    Date of Patent: March 23, 1976
    Assignee: Merck Sharp & Dohme (I.A.) Corporation
    Inventors: Burton Kendall Wasson, Leonard M. Weinstock